About Molecular Partners AG

Company Description

We are pioneers: inventors and developers of an entirely new class of therapeutics.

As our name indicates, collaboration is in our DNA: within our team, with our partners, and with patients and providers. We build on deep trust, individual diversity, and shared passion to reach our common goal of surmounting the toughest challenges in medicine, including the treatment of cancer and other serious diseases.

Our long-term strategy leverages our in-house DARPin design and development expertise combined with the capabilities of world-class partners to deliver a broad pipeline of innovative therapeutics.

Served area

Worldwide

Headcount

163

Headquarters

Wagistrasse 14, 8952 Schlieren – Switzerland

Shareholder information

IPO

Nov. 5, 2014

Stock exchange(s)

SIX Swiss Exchange

Contact

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.